Routine annual meeting results with no surprises. The 20.24% withhold vote for director Sabrina Heltz is notable but not actionable without further context. Monitor for any future equity grant disclosures under the expanded LTIP share reserve.
Price Chart
Executive Summary
Viemed Healthcare filed an 8-K reporting the results of its June 4, 2026 Annual General and Special Meeting. Shareholders approved all proposals: election of all seven director nominees (with Sabrina Heltz receiving 20.24% withheld votes), ratification of Ernst & Young as auditors, an advisory say-on-pay vote, and a second amendment to the 2024 Long Term Incentive Plan increasing the share reserve to 7,696,717 common shares. This is a routine governance filing with no material financial impact.
Key Facts
- Shareholders approved a second amendment to the 2024 LTIP, increasing the maximum share reserve to 7,696,717 common shares (including up to 1,000,000 for incentive stock options).
- All seven director nominees were elected; Sabrina Heltz received the highest withhold vote at 20.24%.
- Ernst & Young LLP was ratified as independent auditors for FY2026 with 97.59% of votes for.
- Advisory say-on-pay vote passed with 93.21% support.
- Broker non-votes totaled 5,139,303 for director elections and the LTIP amendment.
Financial Impact
No financial figures reported. The LTIP amendment increases authorized shares for equity compensation but does not represent immediate dilution or cash impact.
Risk Factors
- Potential future dilution from equity awards under the expanded LTIP.
- Elevated withhold vote for Sabrina Heltz (20.24%) may indicate shareholder governance concerns.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001729149-26-000034 |
| Document: secondamendmentviemedhealt.htm | 0001729149-26-000034 |
| Document: 0001729149-26-000034-index-headers.html | 0001729149-26-000034 |
| Document: 0001729149-26-000034-index.html | 0001729149-26-000034 |
| Document: 0001729149-26-000034.txt | 0001729149-26-000034 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 24, 2026 4w ago | SC 13D/A | $8.91 $9.11 | ▼ −2.24% | ▼ −2.99% | $9.73 (−9.20%) |
Aug 20, 2026 9w ago | 8-K | $8.85 $9.09 | ▲ +2.71% | ▲ +3.01% | $9.73 (+9.94%) |
Aug 3, 2026 12w ago | 8-K | $9.84 $9.82 | ▼ −0.15% | ▲ +0.05% | $9.73 (−1.07%) |
Jun 4, 2026 20w ago | 8-K | $9.97 $9.92 | ▼ −0.50% | ▼ −0.73% | $9.73 (−2.41%) |
Jun 2, 2026 20w ago | 8-K | $9.56 $9.84 | ▲ +2.93% | ▲ +2.53% | $9.73 (+1.78%) |
May 5, 2026 24w ago | 8-K | $8.52 $8.52 | · 0.00% | ▲ +0.33% | $9.73 (+14.27%) |
Mar 4, 2026 33w ago | 8-K | $8.40 $8.78 | ▲ +4.52% | ▲ +5.84% | $9.73 (+15.83%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers